

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle exocytosis (GO:0016079) | 5.81726376 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.48115894 |
| 3 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.23164573 |
| 4 | glutamate secretion (GO:0014047) | 5.15937364 |
| 5 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.01467195 |
| 6 | * transferrin transport (GO:0033572) | 4.87577412 |
| 7 | synaptic vesicle maturation (GO:0016188) | 4.80620077 |
| 8 | * energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 4.71496663 |
| 9 | * ATP hydrolysis coupled proton transport (GO:0015991) | 4.71496663 |
| 10 | vocalization behavior (GO:0071625) | 4.64571922 |
| 11 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.61039610 |
| 12 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.60893237 |
| 13 | * trivalent inorganic cation transport (GO:0072512) | 4.49458391 |
| 14 | * ferric iron transport (GO:0015682) | 4.49458391 |
| 15 | regulation of synaptic vesicle transport (GO:1902803) | 4.48776226 |
| 16 | * phagosome maturation (GO:0090382) | 4.42132489 |
| 17 | neuronal action potential propagation (GO:0019227) | 4.36816716 |
| 18 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.36650396 |
| 19 | neurotransmitter secretion (GO:0007269) | 4.33106173 |
| 20 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.28340063 |
| 21 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.26356222 |
| 22 | neuron cell-cell adhesion (GO:0007158) | 4.18093225 |
| 23 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.07858496 |
| 24 | protein localization to synapse (GO:0035418) | 4.05263386 |
| 25 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.03791586 |
| 26 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.97389537 |
| 27 | locomotory exploration behavior (GO:0035641) | 3.91756129 |
| 28 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.90000386 |
| 29 | neuron-neuron synaptic transmission (GO:0007270) | 3.75512463 |
| 30 | sodium ion export (GO:0071436) | 3.74381757 |
| 31 | synaptic transmission, glutamatergic (GO:0035249) | 3.68580032 |
| 32 | proline transport (GO:0015824) | 3.66560884 |
| 33 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.61197098 |
| 34 | long-term synaptic potentiation (GO:0060291) | 3.59600971 |
| 35 | regulation of early endosome to late endosome transport (GO:2000641) | 3.57620270 |
| 36 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.56715030 |
| 37 | neuromuscular process controlling posture (GO:0050884) | 3.56520739 |
| 38 | glutamate receptor signaling pathway (GO:0007215) | 3.54309797 |
| 39 | negative regulation of amino acid transport (GO:0051956) | 3.46283996 |
| 40 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.44987393 |
| 41 | neurotransmitter transport (GO:0006836) | 3.42451098 |
| 42 | protein localization to endosome (GO:0036010) | 3.40304373 |
| 43 | positive regulation of synapse maturation (GO:0090129) | 3.35215825 |
| 44 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.33355251 |
| 45 | positive regulation of neurotransmitter transport (GO:0051590) | 3.31094206 |
| 46 | postsynaptic membrane organization (GO:0001941) | 3.28608160 |
| 47 | presynaptic membrane assembly (GO:0097105) | 3.28088424 |
| 48 | regulation of neurotransmitter secretion (GO:0046928) | 3.27060403 |
| 49 | gamma-aminobutyric acid transport (GO:0015812) | 3.26244321 |
| 50 | regulation of synapse structural plasticity (GO:0051823) | 3.25902895 |
| 51 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.24955934 |
| 52 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.24713766 |
| 53 | regulation of neurotransmitter levels (GO:0001505) | 3.21290234 |
| 54 | exploration behavior (GO:0035640) | 3.20868156 |
| 55 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.19225911 |
| 56 | positive regulation of membrane potential (GO:0045838) | 3.19047530 |
| 57 | response to histamine (GO:0034776) | 3.18858336 |
| 58 | regulation of glutamate secretion (GO:0014048) | 3.17392152 |
| 59 | synaptic vesicle endocytosis (GO:0048488) | 3.17116078 |
| 60 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.12770135 |
| 61 | regulation of synaptic plasticity (GO:0048167) | 3.11100643 |
| 62 | regulation of neurotransmitter transport (GO:0051588) | 3.08826718 |
| 63 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.07903867 |
| 64 | presynaptic membrane organization (GO:0097090) | 3.05854605 |
| 65 | startle response (GO:0001964) | 3.05058199 |
| 66 | response to peptidoglycan (GO:0032494) | 3.04690599 |
| 67 | regulation of vesicle fusion (GO:0031338) | 3.03454335 |
| 68 | establishment of synaptic vesicle localization (GO:0097480) | 3.02778023 |
| 69 | synaptic vesicle transport (GO:0048489) | 3.02778023 |
| 70 | activation of MAPKKK activity (GO:0000185) | 3.02395244 |
| 71 | regulation of postsynaptic membrane potential (GO:0060078) | 3.02207570 |
| 72 | cellular potassium ion homeostasis (GO:0030007) | 3.02122049 |
| 73 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.00282209 |
| 74 | long-term memory (GO:0007616) | 2.98854593 |
| 75 | positive regulation of synaptic transmission (GO:0050806) | 2.97379441 |
| 76 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.95458001 |
| 77 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.95410325 |
| 78 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.94889924 |
| 79 | cell-cell junction maintenance (GO:0045217) | 2.93820715 |
| 80 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.92955713 |
| 81 | regulation of ARF protein signal transduction (GO:0032012) | 2.90937923 |
| 82 | cerebellar granule cell differentiation (GO:0021707) | 2.89635888 |
| 83 | barbed-end actin filament capping (GO:0051016) | 2.89033308 |
| 84 | synaptic transmission (GO:0007268) | 2.86378846 |
| 85 | * iron ion transport (GO:0006826) | 2.84477792 |
| 86 | modulation by virus of host process (GO:0019054) | 2.83696402 |
| 87 | response to acidic pH (GO:0010447) | 2.83490282 |
| 88 | activation of protein kinase A activity (GO:0034199) | 2.82324230 |
| 89 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.81990479 |
| 90 | negative regulation of cell killing (GO:0031342) | 2.81990479 |
| 91 | NADH metabolic process (GO:0006734) | 2.81205901 |
| 92 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.81059114 |
| 93 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.81059114 |
| 94 | modulation by symbiont of host immune response (GO:0052553) | 2.81059114 |
| 95 | positive regulation by symbiont of host defense response (GO:0052509) | 2.81059114 |
| 96 | modulation by symbiont of host defense response (GO:0052031) | 2.81059114 |
| 97 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.81059114 |
| 98 | regulation of synaptic transmission, dopaminergic (GO:0032225) | 2.80933329 |
| 99 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.80624319 |
| 100 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.80035225 |
| 101 | modulation by symbiont of host cellular process (GO:0044068) | 2.79926779 |
| 102 | regulation of synaptic transmission (GO:0050804) | 2.77615348 |
| 103 | positive regulation of protein dephosphorylation (GO:0035307) | 2.77305541 |
| 104 | regulation of regulated secretory pathway (GO:1903305) | 2.76728515 |
| 105 | serotonin metabolic process (GO:0042428) | 2.76506293 |
| 106 | response to auditory stimulus (GO:0010996) | 2.76362420 |
| 107 | signal complex assembly (GO:0007172) | 2.75541286 |
| 108 | protein retention in ER lumen (GO:0006621) | 2.74534658 |
| 109 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.74528343 |
| 110 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.74189277 |
| 111 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.74189277 |
| 112 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.73514873 |
| 113 | cerebellar Purkinje cell layer development (GO:0021680) | 2.72826272 |
| 114 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.72480394 |
| 115 | behavioral response to cocaine (GO:0048148) | 2.71299309 |
| 116 | regulation of exocytosis (GO:0017157) | 2.70875937 |
| 117 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.70052922 |
| 118 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.68725413 |
| 119 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.68630697 |
| 120 | regulation of synapse maturation (GO:0090128) | 2.67544947 |
| 121 | positive regulation of exocytosis (GO:0045921) | 2.66875707 |
| 122 | establishment of vesicle localization (GO:0051650) | 2.65231319 |
| 123 | membrane depolarization (GO:0051899) | 2.65198105 |
| 124 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.64758558 |
| 125 | macrophage activation involved in immune response (GO:0002281) | 2.64620276 |
| 126 | striatum development (GO:0021756) | 2.64177018 |
| 127 | regulation of leukocyte degranulation (GO:0043300) | 2.62720681 |
| 128 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.62005643 |
| 129 | adenosine receptor signaling pathway (GO:0001973) | 2.61982943 |
| 130 | membrane hyperpolarization (GO:0060081) | 2.59405017 |
| 131 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.58917227 |
| 132 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.58132299 |
| 133 | long term synaptic depression (GO:0060292) | 2.57304771 |
| 134 | neutrophil activation involved in immune response (GO:0002283) | 2.55561672 |
| 135 | regulation of defense response to virus by virus (GO:0050690) | 2.55284751 |
| 136 | dopamine receptor signaling pathway (GO:0007212) | 2.52808316 |
| 137 | response to parathyroid hormone (GO:0071107) | 2.51137741 |
| 138 | regulation of mast cell degranulation (GO:0043304) | 2.49472163 |
| 139 | mannose metabolic process (GO:0006013) | 2.49229315 |
| 140 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.48611679 |
| 141 | neuromuscular process controlling balance (GO:0050885) | 2.47279780 |
| 142 | amino acid import (GO:0043090) | 2.46509398 |
| 143 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.43972836 |
| 144 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.42395241 |
| 145 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.42031240 |
| 146 | stress fiber assembly (GO:0043149) | 2.41935996 |
| 147 | L-amino acid import (GO:0043092) | 2.41488690 |
| 148 | negative regulation of interleukin-12 production (GO:0032695) | 2.41379420 |
| 149 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.40739692 |
| 150 | protein targeting to plasma membrane (GO:0072661) | 2.38817348 |
| 151 | regulation of protein dephosphorylation (GO:0035304) | 2.34715416 |
| 152 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.32996212 |
| 153 | positive regulation of regulated secretory pathway (GO:1903307) | 2.32328899 |
| 154 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.31460356 |
| 155 | mitochondrion transport along microtubule (GO:0047497) | 2.31460356 |
| 156 | adhesion of symbiont to host cell (GO:0044650) | 2.29523520 |
| 157 | virion attachment to host cell (GO:0019062) | 2.29523520 |
| 158 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.28889095 |
| 159 | regulation of ARF GTPase activity (GO:0032312) | 2.27595563 |
| 160 | layer formation in cerebral cortex (GO:0021819) | 2.27547024 |
| 161 | adhesion of symbiont to host (GO:0044406) | 2.25207295 |
| 162 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.23538921 |
| 163 | amino sugar catabolic process (GO:0046348) | 2.21978588 |
| 164 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 2.21045648 |
| 165 | establishment of mitochondrion localization (GO:0051654) | 2.20102060 |
| 166 | response to muramyl dipeptide (GO:0032495) | 2.19124244 |
| 167 | neuronal ion channel clustering (GO:0045161) | 2.18961132 |
| 168 | glycosphingolipid catabolic process (GO:0046479) | 2.18097373 |
| 169 | response to dietary excess (GO:0002021) | 2.17994857 |
| 170 | cell migration in hindbrain (GO:0021535) | 2.17412778 |
| 171 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.16785396 |
| 172 | actin filament polymerization (GO:0030041) | 2.16561759 |
| 173 | respiratory system process (GO:0003016) | 2.15108886 |
| 174 | positive regulation of fibroblast migration (GO:0010763) | 2.14491376 |
| 175 | cell junction maintenance (GO:0034331) | 2.13895537 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.44698835 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.27293085 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.23479704 |
| 4 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 3.11054605 |
| 5 | LXR_22292898_ChIP-Seq_THP-1_Human | 3.08665940 |
| 6 | REST_21632747_ChIP-Seq_MESCs_Mouse | 3.05720643 |
| 7 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.03369437 |
| 8 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.91142179 |
| 9 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.83591299 |
| 10 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.70628834 |
| 11 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.69178801 |
| 12 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.67670744 |
| 13 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.66984267 |
| 14 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.60435563 |
| 15 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.60267202 |
| 16 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.58711567 |
| 17 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.58396127 |
| 18 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.52226026 |
| 19 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.51766246 |
| 20 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.50179935 |
| 21 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.48032743 |
| 22 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.45261298 |
| 23 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.44497158 |
| 24 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.40780284 |
| 25 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.34615728 |
| 26 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.34615728 |
| 27 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.30194415 |
| 28 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.22709256 |
| 29 | KDM2B_26808549_Chip-Seq_K562_Human | 2.20242153 |
| 30 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.15519055 |
| 31 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.13084990 |
| 32 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.12798232 |
| 33 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.12340392 |
| 34 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.07675050 |
| 35 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.05195535 |
| 36 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.03643042 |
| 37 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.01247137 |
| 38 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.96208704 |
| 39 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.96111952 |
| 40 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.95683105 |
| 41 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.94980300 |
| 42 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.94395129 |
| 43 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.90113476 |
| 44 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.86975040 |
| 45 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.86739518 |
| 46 | MYC_22102868_ChIP-Seq_BL_Human | 1.84373883 |
| 47 | P68_20966046_ChIP-Seq_HELA_Human | 1.79938466 |
| 48 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.79752978 |
| 49 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.69660527 |
| 50 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.67237401 |
| 51 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.65708782 |
| 52 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.63581056 |
| 53 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.63539724 |
| 54 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.63283030 |
| 55 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.62883087 |
| 56 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.61622588 |
| 57 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.59958433 |
| 58 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.59010050 |
| 59 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.57833070 |
| 60 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.55912743 |
| 61 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.55336070 |
| 62 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.52039959 |
| 63 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.51594833 |
| 64 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.50134018 |
| 65 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.49497023 |
| 66 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49151204 |
| 67 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.48859533 |
| 68 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.47724575 |
| 69 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.47666018 |
| 70 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.45022766 |
| 71 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.43642835 |
| 72 | P300_19829295_ChIP-Seq_ESCs_Human | 1.41948079 |
| 73 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.41814201 |
| 74 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.41790801 |
| 75 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.41754752 |
| 76 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.41221552 |
| 77 | VDR_22108803_ChIP-Seq_LS180_Human | 1.37685166 |
| 78 | AR_25329375_ChIP-Seq_VCAP_Human | 1.36388580 |
| 79 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.35817920 |
| 80 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.35306824 |
| 81 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.34398657 |
| 82 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.33779325 |
| 83 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.32644020 |
| 84 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.31883030 |
| 85 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.31221304 |
| 86 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.29363605 |
| 87 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.23988622 |
| 88 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.23452788 |
| 89 | MAF_26560356_Chip-Seq_TH1_Human | 1.22346107 |
| 90 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.21496140 |
| 91 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.21016208 |
| 92 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.20721711 |
| 93 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.20631605 |
| 94 | MAF_26560356_Chip-Seq_TH2_Human | 1.20558338 |
| 95 | SA1_27219007_Chip-Seq_Bcells_Human | 1.20239766 |
| 96 | UTX_26944678_Chip-Seq_JUKART_Human | 1.19936253 |
| 97 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.18885831 |
| 98 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17802530 |
| 99 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.16867000 |
| 100 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.16520124 |
| 101 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.15796963 |
| 102 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.14934222 |
| 103 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.14644853 |
| 104 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.14522173 |
| 105 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14348728 |
| 106 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.13593759 |
| 107 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.13383231 |
| 108 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.12141171 |
| 109 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.12118927 |
| 110 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.11962185 |
| 111 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.11566061 |
| 112 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.11372819 |
| 113 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.10725286 |
| 114 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.10057418 |
| 115 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.09842200 |
| 116 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.09788398 |
| 117 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.09482747 |
| 118 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.09172250 |
| 119 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.09156761 |
| 120 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.08394661 |
| 121 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.07301562 |
| 122 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.06844786 |
| 123 | SPI1_23127762_ChIP-Seq_K562_Human | 1.05450035 |
| 124 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.05144451 |
| 125 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.04992424 |
| 126 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.04746673 |
| 127 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.03683744 |
| 128 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.02917043 |
| 129 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.02643898 |
| 130 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.02415441 |
| 131 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.02367566 |
| 132 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.02336003 |
| 133 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.01517472 |
| 134 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.01516238 |
| 135 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.01148831 |
| 136 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.00702726 |
| 137 | JUN_21703547_ChIP-Seq_K562_Human | 0.99950498 |
| 138 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.99024811 |
| 139 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.98812380 |
| 140 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.98530782 |
| 141 | GATA1_19941826_ChIP-Seq_K562_Human | 0.98344666 |
| 142 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.97948438 |
| 143 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.97407887 |
| 144 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.96740593 |
| 145 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.96419991 |
| 146 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.95547045 |
| 147 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.95399240 |
| 148 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.92990646 |
| 149 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.92838034 |
| 150 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92329316 |
| 151 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.92147675 |
| 152 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.92036368 |
| 153 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.90402086 |
| 154 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.89394568 |
| 155 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.88799242 |
| 156 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.88515287 |
| 157 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.86140880 |
| 158 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.85643137 |
| 159 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.85445075 |
| 160 | AR_19668381_ChIP-Seq_PC3_Human | 0.84855952 |
| 161 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.84661519 |
| 162 | STAT3_23295773_ChIP-Seq_U87_Human | 0.84617812 |
| 163 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.83739677 |
| 164 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.82464027 |
| 165 | TCF4_23295773_ChIP-Seq_U87_Human | 0.81544092 |
| 166 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.81470938 |
| 167 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.81036121 |
| 168 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80063872 |
| 169 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.79257724 |
| 170 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.77669823 |
| 171 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77131247 |
| 172 | RXR_22108803_ChIP-Seq_LS180_Human | 0.75868214 |
| 173 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.75644401 |
| 174 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.74590965 |
| 175 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.73681103 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.39550206 |
| 2 | MP0003880_abnormal_central_pattern | 4.56112977 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.73714612 |
| 4 | MP0009046_muscle_twitch | 3.56187979 |
| 5 | MP0002064_seizures | 3.41765252 |
| 6 | MP0009745_abnormal_behavioral_response | 3.36539208 |
| 7 | MP0001968_abnormal_touch/_nociception | 3.27388323 |
| 8 | MP0002063_abnormal_learning/memory/cond | 3.02565473 |
| 9 | MP0002822_catalepsy | 2.94366599 |
| 10 | MP0002736_abnormal_nociception_after | 2.85326210 |
| 11 | MP0002572_abnormal_emotion/affect_behav | 2.72914642 |
| 12 | MP0004270_analgesia | 2.71188527 |
| 13 | MP0001501_abnormal_sleep_pattern | 2.67013281 |
| 14 | MP0002735_abnormal_chemical_nociception | 2.58588408 |
| 15 | MP0009840_abnormal_foam_cell | 2.53635204 |
| 16 | MP0002272_abnormal_nervous_system | 2.46071435 |
| 17 | MP0002734_abnormal_mechanical_nocicepti | 2.40003879 |
| 18 | MP0002733_abnormal_thermal_nociception | 2.11991634 |
| 19 | MP0001970_abnormal_pain_threshold | 2.08248724 |
| 20 | MP0001440_abnormal_grooming_behavior | 2.03270716 |
| 21 | MP0003879_abnormal_hair_cell | 2.03163927 |
| 22 | MP0009278_abnormal_bone_marrow | 2.02150216 |
| 23 | MP0003183_abnormal_peptide_metabolism | 2.01293454 |
| 24 | MP0002067_abnormal_sensory_capabilities | 1.98740774 |
| 25 | MP0001486_abnormal_startle_reflex | 1.92198508 |
| 26 | MP0003123_paternal_imprinting | 1.91476508 |
| 27 | MP0004858_abnormal_nervous_system | 1.90993659 |
| 28 | MP0003705_abnormal_hypodermis_morpholog | 1.90966013 |
| 29 | MP0010386_abnormal_urinary_bladder | 1.88477091 |
| 30 | MP0003122_maternal_imprinting | 1.88294267 |
| 31 | MP0003191_abnormal_cellular_cholesterol | 1.85470005 |
| 32 | MP0003329_amyloid_beta_deposits | 1.80875352 |
| 33 | MP0009780_abnormal_chondrocyte_physiolo | 1.78454394 |
| 34 | MP0005451_abnormal_body_composition | 1.76578572 |
| 35 | MP0005058_abnormal_lysosome_morphology | 1.72871554 |
| 36 | MP0005423_abnormal_somatic_nervous | 1.71732856 |
| 37 | MP0005646_abnormal_pituitary_gland | 1.70841781 |
| 38 | MP0003172_abnormal_lysosome_physiology | 1.70273329 |
| 39 | MP0001905_abnormal_dopamine_level | 1.69285708 |
| 40 | MP0006276_abnormal_autonomic_nervous | 1.68321032 |
| 41 | MP0001984_abnormal_olfaction | 1.63505883 |
| 42 | MP0002909_abnormal_adrenal_gland | 1.59811677 |
| 43 | MP0003787_abnormal_imprinting | 1.59522646 |
| 44 | MP0000343_altered_response_to | 1.57052621 |
| 45 | MP0008569_lethality_at_weaning | 1.55025416 |
| 46 | MP0004924_abnormal_behavior | 1.54601361 |
| 47 | MP0005386_behavior/neurological_phenoty | 1.54601361 |
| 48 | MP0001529_abnormal_vocalization | 1.53770536 |
| 49 | MP0004811_abnormal_neuron_physiology | 1.53683658 |
| 50 | MP0005025_abnormal_response_to | 1.52010004 |
| 51 | MP0004142_abnormal_muscle_tone | 1.47006578 |
| 52 | MP0005464_abnormal_platelet_physiology | 1.46962669 |
| 53 | MP0003300_gastrointestinal_ulcer | 1.46403061 |
| 54 | MP0002557_abnormal_social/conspecific_i | 1.45416634 |
| 55 | MP0002184_abnormal_innervation | 1.43356075 |
| 56 | MP0000678_abnormal_parathyroid_gland | 1.43069606 |
| 57 | MP0003453_abnormal_keratinocyte_physiol | 1.40552212 |
| 58 | MP0005000_abnormal_immune_tolerance | 1.38756197 |
| 59 | MP0002876_abnormal_thyroid_physiology | 1.36452406 |
| 60 | MP0001533_abnormal_skeleton_physiology | 1.36166877 |
| 61 | MP0000604_amyloidosis | 1.35923632 |
| 62 | MP0005409_darkened_coat_color | 1.34642302 |
| 63 | MP0005623_abnormal_meninges_morphology | 1.33723102 |
| 64 | MP0004947_skin_inflammation | 1.33676462 |
| 65 | MP0001502_abnormal_circadian_rhythm | 1.33074106 |
| 66 | MP0005645_abnormal_hypothalamus_physiol | 1.30773396 |
| 67 | MP0003303_peritoneal_inflammation | 1.29264395 |
| 68 | MP0002066_abnormal_motor_capabilities/c | 1.28832360 |
| 69 | MP0003075_altered_response_to | 1.28661502 |
| 70 | MP0003633_abnormal_nervous_system | 1.28482459 |
| 71 | MP0000858_altered_metastatic_potential | 1.23003875 |
| 72 | MP0003724_increased_susceptibility_to | 1.21525571 |
| 73 | MP0002998_abnormal_bone_remodeling | 1.20439143 |
| 74 | MP0002877_abnormal_melanocyte_morpholog | 1.18394775 |
| 75 | MP0008260_abnormal_autophagy | 1.14142124 |
| 76 | MP0001790_abnormal_immune_system | 1.13810982 |
| 77 | MP0005387_immune_system_phenotype | 1.13810982 |
| 78 | MP0001348_abnormal_lacrimal_gland | 1.12277142 |
| 79 | MP0000955_abnormal_spinal_cord | 1.10835274 |
| 80 | MP0002249_abnormal_larynx_morphology | 1.09952135 |
| 81 | MP0002882_abnormal_neuron_morphology | 1.09566678 |
| 82 | MP0000013_abnormal_adipose_tissue | 1.09437692 |
| 83 | MP0004510_myositis | 1.07022929 |
| 84 | MP0001849_ear_inflammation | 1.06931992 |
| 85 | MP0005671_abnormal_response_to | 1.06208973 |
| 86 | MP0003631_nervous_system_phenotype | 1.05964219 |
| 87 | MP0005535_abnormal_body_temperature | 1.04287709 |
| 88 | MP0009785_altered_susceptibility_to | 1.03860727 |
| 89 | MP0001986_abnormal_taste_sensitivity | 1.02558838 |
| 90 | MP0004185_abnormal_adipocyte_glucose | 1.01763872 |
| 91 | MP0004043_abnormal_pH_regulation | 1.01184375 |
| 92 | MP0005171_absent_coat_pigmentation | 0.98429715 |
| 93 | MP0000685_abnormal_immune_system | 0.97937438 |
| 94 | MP0009333_abnormal_splenocyte_physiolog | 0.97538223 |
| 95 | MP0002229_neurodegeneration | 0.97033879 |
| 96 | MP0003279_aneurysm | 0.96965762 |
| 97 | MP0002723_abnormal_immune_serum | 0.96548918 |
| 98 | MP0002837_dystrophic_cardiac_calcinosis | 0.93488610 |
| 99 | MP0002638_abnormal_pupillary_reflex | 0.92693407 |
| 100 | MP0002090_abnormal_vision | 0.92544982 |
| 101 | MP0002420_abnormal_adaptive_immunity | 0.92447289 |
| 102 | MP0008872_abnormal_physiological_respon | 0.92328660 |
| 103 | MP0002069_abnormal_eating/drinking_beha | 0.91628497 |
| 104 | MP0001819_abnormal_immune_cell | 0.91042677 |
| 105 | MP0001188_hyperpigmentation | 0.90655407 |
| 106 | MP0003690_abnormal_glial_cell | 0.90639010 |
| 107 | MP0001545_abnormal_hematopoietic_system | 0.89975220 |
| 108 | MP0005397_hematopoietic_system_phenotyp | 0.89975220 |
| 109 | MP0003646_muscle_fatigue | 0.89897834 |
| 110 | MP0002089_abnormal_postnatal_growth/wei | 0.89796295 |
| 111 | MP0000751_myopathy | 0.88999356 |
| 112 | MP0003634_abnormal_glial_cell | 0.87035260 |
| 113 | MP0002452_abnormal_antigen_presenting | 0.86237702 |
| 114 | MP0005076_abnormal_cell_differentiation | 0.85758480 |
| 115 | MP0008874_decreased_physiological_sensi | 0.85515114 |
| 116 | MP0005083_abnormal_biliary_tract | 0.85187128 |
| 117 | MP0000778_abnormal_nervous_system | 0.84962399 |
| 118 | MP0002332_abnormal_exercise_endurance | 0.84661782 |
| 119 | MP0006082_CNS_inflammation | 0.83276602 |
| 120 | MP0005666_abnormal_adipose_tissue | 0.82619713 |
| 121 | MP0005310_abnormal_salivary_gland | 0.81990848 |
| 122 | MP0001542_abnormal_bone_strength | 0.78392270 |
| 123 | MP0004130_abnormal_muscle_cell | 0.76914913 |
| 124 | MP0005390_skeleton_phenotype | 0.76706527 |
| 125 | MP0001963_abnormal_hearing_physiology | 0.76604990 |
| 126 | MP0001835_abnormal_antigen_presentation | 0.75943889 |
| 127 | MP0002796_impaired_skin_barrier | 0.72532629 |
| 128 | MP0005375_adipose_tissue_phenotype | 0.72434163 |
| 129 | MP0001845_abnormal_inflammatory_respons | 0.71400517 |
| 130 | MP0003632_abnormal_nervous_system | 0.71155648 |
| 131 | MP0001664_abnormal_digestion | 0.69703871 |
| 132 | MP0005167_abnormal_blood-brain_barrier | 0.69187660 |
| 133 | MP0004742_abnormal_vestibular_system | 0.68320543 |
| 134 | MP0005551_abnormal_eye_electrophysiolog | 0.67777179 |
| 135 | MP0001800_abnormal_humoral_immune | 0.67639539 |
| 136 | MP0005166_decreased_susceptibility_to | 0.65096668 |
| 137 | MP0002148_abnormal_hypersensitivity_rea | 0.63366104 |
| 138 | MP0002152_abnormal_brain_morphology | 0.63318842 |
| 139 | MP0000681_abnormal_thyroid_gland | 0.62889561 |
| 140 | MP0004885_abnormal_endolymph | 0.59281251 |
| 141 | MP0008004_abnormal_stomach_pH | 0.55730012 |
| 142 | MP0005448_abnormal_energy_balance | 0.55542584 |
| 143 | MP0002419_abnormal_innate_immunity | 0.54439912 |
| 144 | MP0004484_altered_response_of | 0.53884621 |
| 145 | MP0003436_decreased_susceptibility_to | 0.53683806 |
| 146 | MP0008961_abnormal_basal_metabolism | 0.52648871 |
| 147 | MP0003195_calcinosis | 0.52602304 |
| 148 | MP0002653_abnormal_ependyma_morphology | 0.52504150 |
| 149 | MP0000920_abnormal_myelination | 0.51243677 |
| 150 | MP0001765_abnormal_ion_homeostasis | 0.50327798 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.32296372 |
| 2 | Myokymia (HP:0002411) | 5.52519153 |
| 3 | Atonic seizures (HP:0010819) | 5.38562637 |
| 4 | Epileptic encephalopathy (HP:0200134) | 5.15941468 |
| 5 | Focal seizures (HP:0007359) | 4.78804563 |
| 6 | Febrile seizures (HP:0002373) | 4.60770758 |
| 7 | Visual hallucinations (HP:0002367) | 4.47775677 |
| 8 | Absence seizures (HP:0002121) | 4.30984895 |
| 9 | Dialeptic seizures (HP:0011146) | 4.01594108 |
| 10 | Neurofibrillary tangles (HP:0002185) | 4.01046080 |
| 11 | Generalized tonic-clonic seizures (HP:0002069) | 3.78316939 |
| 12 | Polyphagia (HP:0002591) | 3.73046071 |
| 13 | Failure to thrive in infancy (HP:0001531) | 3.63480795 |
| 14 | Pheochromocytoma (HP:0002666) | 3.62862661 |
| 15 | Abnormal eating behavior (HP:0100738) | 3.51442012 |
| 16 | Neuroendocrine neoplasm (HP:0100634) | 3.47874550 |
| 17 | Cerebral inclusion bodies (HP:0100314) | 3.47477506 |
| 18 | Progressive cerebellar ataxia (HP:0002073) | 3.43275220 |
| 19 | Obstructive sleep apnea (HP:0002870) | 3.42180404 |
| 20 | Abnormal hair whorl (HP:0010721) | 3.40449064 |
| 21 | Hyperventilation (HP:0002883) | 3.38547379 |
| 22 | Increased cerebral lipofuscin (HP:0011813) | 3.34397917 |
| 23 | Abnormality of macrophages (HP:0004311) | 3.01066505 |
| 24 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.96307979 |
| 25 | Abnormality of glycolipid metabolism (HP:0010969) | 2.92745322 |
| 26 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.92745322 |
| 27 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.92745322 |
| 28 | Axonal loss (HP:0003447) | 2.92408110 |
| 29 | Supranuclear gaze palsy (HP:0000605) | 2.90906376 |
| 30 | Purpura (HP:0000979) | 2.87898304 |
| 31 | Loss of speech (HP:0002371) | 2.87081501 |
| 32 | Eczematoid dermatitis (HP:0000976) | 2.84151779 |
| 33 | Mutism (HP:0002300) | 2.80412004 |
| 34 | Apathy (HP:0000741) | 2.77292303 |
| 35 | Oligomenorrhea (HP:0000876) | 2.77128371 |
| 36 | Diplopia (HP:0000651) | 2.76518011 |
| 37 | Abnormality of binocular vision (HP:0011514) | 2.76518011 |
| 38 | Poor suck (HP:0002033) | 2.76012039 |
| 39 | Diminished motivation (HP:0000745) | 2.69917165 |
| 40 | Limb dystonia (HP:0002451) | 2.68719313 |
| 41 | Depression (HP:0000716) | 2.67086861 |
| 42 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.61932254 |
| 43 | Progressive inability to walk (HP:0002505) | 2.59975076 |
| 44 | Dysostosis multiplex (HP:0000943) | 2.57697411 |
| 45 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.54866729 |
| 46 | Systemic lupus erythematosus (HP:0002725) | 2.54681327 |
| 47 | Achilles tendon contracture (HP:0001771) | 2.51551647 |
| 48 | Anxiety (HP:0000739) | 2.49791464 |
| 49 | Nuclear cataract (HP:0100018) | 2.49662219 |
| 50 | Acute necrotizing encephalopathy (HP:0006965) | 2.49031313 |
| 51 | Epileptiform EEG discharges (HP:0011182) | 2.47573152 |
| 52 | Gaze-evoked nystagmus (HP:0000640) | 2.42137926 |
| 53 | Hyperparathyroidism (HP:0000843) | 2.40472181 |
| 54 | Annular pancreas (HP:0001734) | 2.40287475 |
| 55 | Chronic obstructive pulmonary disease (HP:0006510) | 2.39633627 |
| 56 | Obstructive lung disease (HP:0006536) | 2.39633627 |
| 57 | Peripheral hypomyelination (HP:0007182) | 2.39302752 |
| 58 | Broad-based gait (HP:0002136) | 2.35353496 |
| 59 | Hyperthyroidism (HP:0000836) | 2.35034102 |
| 60 | Gait imbalance (HP:0002141) | 2.32078258 |
| 61 | Upper limb amyotrophy (HP:0009129) | 2.31587198 |
| 62 | Distal upper limb amyotrophy (HP:0007149) | 2.31587198 |
| 63 | Vertebral compression fractures (HP:0002953) | 2.31423549 |
| 64 | Action tremor (HP:0002345) | 2.30284919 |
| 65 | Amblyopia (HP:0000646) | 2.28949588 |
| 66 | Dysdiadochokinesis (HP:0002075) | 2.26703996 |
| 67 | Neuronal loss in central nervous system (HP:0002529) | 2.26400053 |
| 68 | Poor eye contact (HP:0000817) | 2.25914068 |
| 69 | Abnormality of the Achilles tendon (HP:0005109) | 2.23417357 |
| 70 | EEG with generalized epileptiform discharges (HP:0011198) | 2.23091128 |
| 71 | Petechiae (HP:0000967) | 2.22552913 |
| 72 | Amyloidosis (HP:0011034) | 2.22374264 |
| 73 | Disinhibition (HP:0000734) | 2.21570648 |
| 74 | Bradykinesia (HP:0002067) | 2.21180682 |
| 75 | Truncal ataxia (HP:0002078) | 2.21179916 |
| 76 | Hypoventilation (HP:0002791) | 2.20093543 |
| 77 | Dysmetria (HP:0001310) | 2.18105171 |
| 78 | Nephrogenic diabetes insipidus (HP:0009806) | 2.18051864 |
| 79 | Congenital primary aphakia (HP:0007707) | 2.17397650 |
| 80 | Resting tremor (HP:0002322) | 2.15503488 |
| 81 | Ankle clonus (HP:0011448) | 2.15037056 |
| 82 | Recurrent abscess formation (HP:0002722) | 2.12314655 |
| 83 | Postural instability (HP:0002172) | 2.12086827 |
| 84 | Status epilepticus (HP:0002133) | 2.12077186 |
| 85 | Inability to walk (HP:0002540) | 2.11500791 |
| 86 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.11415066 |
| 87 | Impaired social interactions (HP:0000735) | 2.11136987 |
| 88 | Abnormal social behavior (HP:0012433) | 2.11136987 |
| 89 | Slow saccadic eye movements (HP:0000514) | 2.10481642 |
| 90 | Mitochondrial inheritance (HP:0001427) | 2.09780941 |
| 91 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.08567668 |
| 92 | Medial flaring of the eyebrow (HP:0010747) | 2.08216963 |
| 93 | Hypsarrhythmia (HP:0002521) | 2.07390281 |
| 94 | Progressive macrocephaly (HP:0004481) | 2.06628573 |
| 95 | Psychosis (HP:0000709) | 2.06405508 |
| 96 | Hyperacusis (HP:0010780) | 2.05853998 |
| 97 | Generalized myoclonic seizures (HP:0002123) | 2.05230423 |
| 98 | Torticollis (HP:0000473) | 2.04865900 |
| 99 | Craniofacial dystonia (HP:0012179) | 2.03614516 |
| 100 | Stridor (HP:0010307) | 2.03155032 |
| 101 | Distal lower limb muscle weakness (HP:0009053) | 2.01430499 |
| 102 | Focal dystonia (HP:0004373) | 2.01423549 |
| 103 | Tetraplegia (HP:0002445) | 2.00426378 |
| 104 | Vacuolated lymphocytes (HP:0001922) | 1.99050090 |
| 105 | Hypercortisolism (HP:0001578) | 1.99028522 |
| 106 | Mediastinal lymphadenopathy (HP:0100721) | 1.97773085 |
| 107 | Hypothermia (HP:0002045) | 1.97618326 |
| 108 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.97266341 |
| 109 | Mucopolysacchariduria (HP:0008155) | 1.97266341 |
| 110 | Rapidly progressive (HP:0003678) | 1.95429776 |
| 111 | J-shaped sella turcica (HP:0002680) | 1.94835004 |
| 112 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.94555103 |
| 113 | Increased IgE level (HP:0003212) | 1.93551497 |
| 114 | Abnormal gallbladder physiology (HP:0012438) | 1.93341757 |
| 115 | Cholecystitis (HP:0001082) | 1.93341757 |
| 116 | Hand muscle atrophy (HP:0009130) | 1.93272510 |
| 117 | Cellulitis (HP:0100658) | 1.93096426 |
| 118 | Hip dysplasia (HP:0001385) | 1.93091846 |
| 119 | Insomnia (HP:0100785) | 1.92951770 |
| 120 | Delusions (HP:0000746) | 1.92281863 |
| 121 | Hepatocellular necrosis (HP:0001404) | 1.92055457 |
| 122 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.91547183 |
| 123 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.91547183 |
| 124 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.91547183 |
| 125 | Rigidity (HP:0002063) | 1.91040169 |
| 126 | Specific learning disability (HP:0001328) | 1.90734383 |
| 127 | Polygenic inheritance (HP:0010982) | 1.90678092 |
| 128 | Fetal akinesia sequence (HP:0001989) | 1.89777146 |
| 129 | Esotropia (HP:0000565) | 1.88673085 |
| 130 | Spinal canal stenosis (HP:0003416) | 1.88491946 |
| 131 | Bulbar palsy (HP:0001283) | 1.88274234 |
| 132 | Iris hypopigmentation (HP:0007730) | 1.88196861 |
| 133 | Progressive neurologic deterioration (HP:0002344) | 1.86619786 |
| 134 | Agitation (HP:0000713) | 1.86334374 |
| 135 | Dementia (HP:0000726) | 1.86192298 |
| 136 | Recurrent bacterial skin infections (HP:0005406) | 1.84875599 |
| 137 | Cerebral aneurysm (HP:0004944) | 1.84416106 |
| 138 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.82778564 |
| 139 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.82391127 |
| 140 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.82123867 |
| 141 | Myoclonus (HP:0001336) | 1.82033357 |
| 142 | Esophageal neoplasm (HP:0100751) | 1.81369021 |
| 143 | Neoplasm of head and neck (HP:0012288) | 1.81369021 |
| 144 | Cortical visual impairment (HP:0100704) | 1.80865219 |
| 145 | Generalized hypopigmentation (HP:0007513) | 1.80831228 |
| 146 | Upper motor neuron abnormality (HP:0002127) | 1.80168886 |
| 147 | Pathologic fracture (HP:0002756) | 1.78777722 |
| 148 | Increased serum ferritin (HP:0003281) | 1.76894324 |
| 149 | Distal lower limb amyotrophy (HP:0008944) | 1.76323797 |
| 150 | Ocular albinism (HP:0001107) | 1.75465438 |
| 151 | Abnormality of the nasal mucosa (HP:0000433) | 1.75237028 |
| 152 | Growth hormone excess (HP:0000845) | 1.74672715 |
| 153 | Long palpebral fissure (HP:0000637) | 1.73526357 |
| 154 | Hypertensive crisis (HP:0100735) | 1.72630315 |
| 155 | Personality changes (HP:0000751) | 1.72562897 |
| 156 | Truncus arteriosus (HP:0001660) | 1.71428248 |
| 157 | Urticaria (HP:0001025) | 1.70332160 |
| 158 | Myositis (HP:0100614) | 1.69743567 |
| 159 | Genu recurvatum (HP:0002816) | 1.66744649 |
| 160 | Spastic gait (HP:0002064) | 1.65485902 |
| 161 | Lower limb amyotrophy (HP:0007210) | 1.65348329 |
| 162 | Prolonged neonatal jaundice (HP:0006579) | 1.65244505 |
| 163 | Urinary incontinence (HP:0000020) | 1.63926824 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 4.35014804 |
| 2 | MAP3K12 | 4.26154910 |
| 3 | NTRK3 | 3.75639554 |
| 4 | EPHA4 | 3.12367234 |
| 5 | MAP3K9 | 3.08953595 |
| 6 | TRIB3 | 2.99364058 |
| 7 | RIPK4 | 2.98405293 |
| 8 | ERN1 | 2.88126490 |
| 9 | ARAF | 2.87475819 |
| 10 | DAPK2 | 2.78428219 |
| 11 | MAP2K7 | 2.73936792 |
| 12 | MAP3K4 | 2.57125436 |
| 13 | DAPK1 | 2.50189566 |
| 14 | CDK19 | 2.43168780 |
| 15 | PLK2 | 2.35855836 |
| 16 | TAOK2 | 2.12545530 |
| 17 | MINK1 | 2.11092497 |
| 18 | SIK1 | 2.05301832 |
| 19 | IRAK3 | 2.02999498 |
| 20 | PRPF4B | 1.98631431 |
| 21 | NME2 | 1.93457000 |
| 22 | ICK | 1.85616184 |
| 23 | RIPK1 | 1.80588514 |
| 24 | GRK5 | 1.79981031 |
| 25 | TESK2 | 1.75453384 |
| 26 | CAMKK2 | 1.69998401 |
| 27 | KSR2 | 1.66676310 |
| 28 | SMG1 | 1.65448918 |
| 29 | MAP2K3 | 1.64268456 |
| 30 | MAP2K4 | 1.63490577 |
| 31 | CCNB1 | 1.61433974 |
| 32 | AKT3 | 1.55163601 |
| 33 | SIK3 | 1.54626071 |
| 34 | MARK2 | 1.51433032 |
| 35 | PAK6 | 1.44063895 |
| 36 | CAMKK1 | 1.40813060 |
| 37 | BRAF | 1.40510287 |
| 38 | TSSK6 | 1.38838649 |
| 39 | PRKCG | 1.33328931 |
| 40 | MAP3K3 | 1.32729664 |
| 41 | NTRK1 | 1.28599116 |
| 42 | MAP4K1 | 1.26380873 |
| 43 | FES | 1.23993241 |
| 44 | NTRK2 | 1.21013674 |
| 45 | CDK5 | 1.20636292 |
| 46 | MAP3K13 | 1.19485957 |
| 47 | OXSR1 | 1.17897290 |
| 48 | MARK1 | 1.11355333 |
| 49 | NME1 | 1.10604234 |
| 50 | PRKD2 | 1.07379448 |
| 51 | TBK1 | 1.05140978 |
| 52 | BMPR2 | 1.01754405 |
| 53 | TYRO3 | 0.98978563 |
| 54 | MAPK12 | 0.97658295 |
| 55 | CAMK2A | 0.96955087 |
| 56 | GRK6 | 0.95790649 |
| 57 | DAPK3 | 0.95731214 |
| 58 | CDK12 | 0.92874560 |
| 59 | PTK2B | 0.91077686 |
| 60 | KSR1 | 0.89708449 |
| 61 | IRAK4 | 0.89319897 |
| 62 | CDC42BPA | 0.88138362 |
| 63 | CDK18 | 0.86949418 |
| 64 | SGK223 | 0.86097381 |
| 65 | SGK494 | 0.86097381 |
| 66 | GRK7 | 0.85737624 |
| 67 | IRAK2 | 0.84749078 |
| 68 | CDK14 | 0.83474601 |
| 69 | NEK1 | 0.82828175 |
| 70 | MAP3K1 | 0.82681947 |
| 71 | HIPK2 | 0.82620515 |
| 72 | CAMK2B | 0.82400063 |
| 73 | ZAP70 | 0.81100288 |
| 74 | CDK15 | 0.79543789 |
| 75 | EPHB1 | 0.78181192 |
| 76 | SGK2 | 0.78054862 |
| 77 | CSK | 0.77001521 |
| 78 | MAP3K2 | 0.75840898 |
| 79 | LATS2 | 0.75121432 |
| 80 | PRKCE | 0.74648639 |
| 81 | DDR2 | 0.71515622 |
| 82 | FGR | 0.70544027 |
| 83 | CDK11A | 0.69106160 |
| 84 | PRKG2 | 0.67832243 |
| 85 | ADRBK2 | 0.67604027 |
| 86 | CAMK1D | 0.67507220 |
| 87 | PRKCH | 0.67163550 |
| 88 | STK38 | 0.65565310 |
| 89 | DYRK1B | 0.65265668 |
| 90 | MAPK13 | 0.64596480 |
| 91 | RPS6KL1 | 0.64212815 |
| 92 | RPS6KC1 | 0.64212815 |
| 93 | MAP2K2 | 0.63140814 |
| 94 | SIK2 | 0.62876569 |
| 95 | UHMK1 | 0.60675087 |
| 96 | RAF1 | 0.60345098 |
| 97 | MYLK | 0.60190875 |
| 98 | TESK1 | 0.59819295 |
| 99 | CAMK2G | 0.59002705 |
| 100 | PTK6 | 0.58613036 |
| 101 | CAMK1 | 0.58285098 |
| 102 | SGK3 | 0.57771745 |
| 103 | SYK | 0.56987919 |
| 104 | PDPK1 | 0.56985119 |
| 105 | TYK2 | 0.56973374 |
| 106 | LMTK2 | 0.56271667 |
| 107 | WNK3 | 0.55697764 |
| 108 | MAP3K11 | 0.55263615 |
| 109 | STK11 | 0.54965296 |
| 110 | CAMK2D | 0.53466180 |
| 111 | ALK | 0.53221594 |
| 112 | PRKD3 | 0.52903467 |
| 113 | PKN2 | 0.52756897 |
| 114 | PINK1 | 0.52358730 |
| 115 | PIM2 | 0.51929220 |
| 116 | TNIK | 0.51840168 |
| 117 | EEF2K | 0.51771141 |
| 118 | TAOK1 | 0.51092395 |
| 119 | PDK1 | 0.50702003 |
| 120 | PDK2 | 0.49774062 |
| 121 | DMPK | 0.48661612 |
| 122 | PDK4 | 0.47531545 |
| 123 | PDK3 | 0.47531545 |
| 124 | MAP2K1 | 0.46411791 |
| 125 | PTK2 | 0.46292484 |
| 126 | BMX | 0.46164413 |
| 127 | ADRBK1 | 0.45359053 |
| 128 | RPS6KA6 | 0.45060807 |
| 129 | LIMK1 | 0.44301183 |
| 130 | MAPK4 | 0.43936392 |
| 131 | SCYL2 | 0.42419563 |
| 132 | LRRK2 | 0.41792784 |
| 133 | RPS6KA2 | 0.41015841 |
| 134 | MOS | 0.40702005 |
| 135 | SGK1 | 0.40152710 |
| 136 | MATK | 0.37353444 |
| 137 | PAK1 | 0.37265143 |
| 138 | BLK | 0.37062942 |
| 139 | DYRK1A | 0.32592261 |
| 140 | TNK2 | 0.32120002 |
| 141 | CSNK1G2 | 0.31764143 |
| 142 | MAP3K14 | 0.31322744 |
| 143 | PRKCA | 0.31042049 |
| 144 | FER | 0.30817297 |
| 145 | PRKCD | 0.30293573 |
| 146 | ABL2 | 0.28188894 |
| 147 | FYN | 0.28025495 |
| 148 | ERBB4 | 0.27730896 |
| 149 | CAMK4 | 0.27709499 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Synaptic vesicle cycle_Homo sapiens_hsa04721 | 4.80843385 |
| 2 | * Collecting duct acid secretion_Homo sapiens_hsa04966 | 4.01182107 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 3.50635547 |
| 4 | * Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.75517899 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.46360882 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.40215659 |
| 7 | Olfactory transduction_Homo sapiens_hsa04740 | 2.34483278 |
| 8 | Morphine addiction_Homo sapiens_hsa05032 | 2.23654825 |
| 9 | Circadian entrainment_Homo sapiens_hsa04713 | 2.16868751 |
| 10 | * Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.03728517 |
| 11 | Long-term potentiation_Homo sapiens_hsa04720 | 2.01871956 |
| 12 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.01780438 |
| 13 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.99480721 |
| 14 | * Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.94484140 |
| 15 | * Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.88764270 |
| 16 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.82371095 |
| 17 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.80189477 |
| 18 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.73932741 |
| 19 | Insulin secretion_Homo sapiens_hsa04911 | 1.71565809 |
| 20 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.68912110 |
| 21 | * Phagosome_Homo sapiens_hsa04145 | 1.62354132 |
| 22 | Salivary secretion_Homo sapiens_hsa04970 | 1.57581336 |
| 23 | Taste transduction_Homo sapiens_hsa04742 | 1.57243406 |
| 24 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.50037064 |
| 25 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.47772060 |
| 26 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.47454378 |
| 27 | Cocaine addiction_Homo sapiens_hsa05030 | 1.44405939 |
| 28 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.44126793 |
| 29 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.43178457 |
| 30 | * Lysosome_Homo sapiens_hsa04142 | 1.41526819 |
| 31 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.41014350 |
| 32 | Long-term depression_Homo sapiens_hsa04730 | 1.37550918 |
| 33 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.33076576 |
| 34 | Parkinsons disease_Homo sapiens_hsa05012 | 1.31535771 |
| 35 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.29432037 |
| 36 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.28549502 |
| 37 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.27028754 |
| 38 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.20476765 |
| 39 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.19951409 |
| 40 | Alzheimers disease_Homo sapiens_hsa05010 | 1.18391861 |
| 41 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.16522747 |
| 42 | Bladder cancer_Homo sapiens_hsa05219 | 1.14551337 |
| 43 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.12301044 |
| 44 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.12201157 |
| 45 | Renin secretion_Homo sapiens_hsa04924 | 1.10046329 |
| 46 | Malaria_Homo sapiens_hsa05144 | 1.08378774 |
| 47 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.07611984 |
| 48 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.06533146 |
| 49 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.04730834 |
| 50 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.02757358 |
| 51 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.98150446 |
| 52 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.97718425 |
| 53 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.97543470 |
| 54 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.93206191 |
| 55 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.91612822 |
| 56 | Gap junction_Homo sapiens_hsa04540 | 0.88133380 |
| 57 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.85874293 |
| 58 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.85722060 |
| 59 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.85031320 |
| 60 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.84727192 |
| 61 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.84407272 |
| 62 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.84269914 |
| 63 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.83905036 |
| 64 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.82967570 |
| 65 | Amoebiasis_Homo sapiens_hsa05146 | 0.82948256 |
| 66 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.81618369 |
| 67 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.81345131 |
| 68 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.81304005 |
| 69 | * Tuberculosis_Homo sapiens_hsa05152 | 0.80727177 |
| 70 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.80025464 |
| 71 | Other glycan degradation_Homo sapiens_hsa00511 | 0.78881156 |
| 72 | Huntingtons disease_Homo sapiens_hsa05016 | 0.76386399 |
| 73 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.75066716 |
| 74 | Endometrial cancer_Homo sapiens_hsa05213 | 0.74029729 |
| 75 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.72818980 |
| 76 | Sulfur relay system_Homo sapiens_hsa04122 | 0.70901624 |
| 77 | Hepatitis C_Homo sapiens_hsa05160 | 0.70574547 |
| 78 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.70182940 |
| 79 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.70012838 |
| 80 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.69718521 |
| 81 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.67271847 |
| 82 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.65460403 |
| 83 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.64572684 |
| 84 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.64414894 |
| 85 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.64062911 |
| 86 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.63828115 |
| 87 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.63571285 |
| 88 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.63261137 |
| 89 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.63062315 |
| 90 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.63032020 |
| 91 | Phototransduction_Homo sapiens_hsa04744 | 0.62503274 |
| 92 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.61560593 |
| 93 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.60960151 |
| 94 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.60282254 |
| 95 | Apoptosis_Homo sapiens_hsa04210 | 0.59815142 |
| 96 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.58634360 |
| 97 | Glioma_Homo sapiens_hsa05214 | 0.56969143 |
| 98 | Salmonella infection_Homo sapiens_hsa05132 | 0.56626147 |
| 99 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.55010259 |
| 100 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.54158722 |
| 101 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.54138016 |
| 102 | Prion diseases_Homo sapiens_hsa05020 | 0.52732359 |
| 103 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.50568241 |
| 104 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.49954539 |
| 105 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.49369210 |
| 106 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.48492322 |
| 107 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.47645562 |
| 108 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.46144295 |
| 109 | Endocytosis_Homo sapiens_hsa04144 | 0.45435252 |
| 110 | Melanogenesis_Homo sapiens_hsa04916 | 0.44929220 |
| 111 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.44606834 |
| 112 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.43820615 |
| 113 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.42286948 |
| 114 | Pertussis_Homo sapiens_hsa05133 | 0.41369751 |
| 115 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.41003280 |
| 116 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.39575730 |
| 117 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.36473682 |
| 118 | Legionellosis_Homo sapiens_hsa05134 | 0.36278981 |
| 119 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.34742318 |
| 120 | Leishmaniasis_Homo sapiens_hsa05140 | 0.31971697 |
| 121 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.30942815 |
| 122 | Galactose metabolism_Homo sapiens_hsa00052 | 0.30492692 |
| 123 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.30159156 |
| 124 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.30007571 |
| 125 | Mineral absorption_Homo sapiens_hsa04978 | 0.28844880 |
| 126 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.27324050 |
| 127 | Asthma_Homo sapiens_hsa05310 | 0.26237227 |
| 128 | Axon guidance_Homo sapiens_hsa04360 | 0.25617911 |
| 129 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.25164012 |
| 130 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.24862546 |
| 131 | Shigellosis_Homo sapiens_hsa05131 | 0.24737529 |
| 132 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.24248222 |
| 133 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.23820374 |
| 134 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.23818558 |
| 135 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.23209482 |
| 136 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.22538611 |

